Relation between


Journal

Sexually transmitted infections
ISSN: 1472-3263
Titre abrégé: Sex Transm Infect
Pays: England
ID NLM: 9805554

Informations de publication

Date de publication:
06 2019
Historique:
received: 25 07 2018
revised: 30 10 2018
accepted: 15 11 2018
pubmed: 5 1 2019
medline: 5 11 2019
entrez: 5 1 2019
Statut: ppublish

Résumé

A better understanding of Women who participated in the CSI 2008-2011 (n=13 498) were invited in 2015-2016 for NECCST. Chlamydia positive was defined as a positive CSI-PCR test, positive chlamydia serology and/or self-reported infection (time dependent). Data on PID, ectopic pregnancy and TFI were collected by self-completed questionnaires. Incidence rates and HRs were compared between chlamydia-positive and chlamydia-negative women corrected for confounders. Of 5704 women included, 29.5% (95% CI 28.3 to 30.7) were chlamydia positive. The incidence rate of PID was 1.8 per 1000 person-years (py) (1.6 to 2.2) overall, 4.4 per 1000 py (3.3 to 5.7) among chlamydia positives compared with 1.4 per 1000 py (1.1 to 1.7) for chlamydia negatives. For TFI, this was 0.4 per 1000 py (0.3 to 0.5) overall, 1.3 per 1000 py (0.8 to 2.1) and 0.2 per 1000 py (0.1 to 0.4) among chlamydia positives and negatives, respectively. And for ectopic pregnancy, this was 0.6 per 1000 py (0.5 to 0.8) overall, 0.8 per 1000 py (0.4 to 1.5) and 0.6 per 1000 py (0.4 to 0.8) for chlamydia negatives. Among chlamydia-positive women, the strongest risk factor for PID was symptomatic versus asymptomatic infection (adjusted HR 2.88, 1.4 to 4.5) and for TFI age <20 versus >24 years at first infection (HR 4.35, 1.1 to 16.8). We found a considerably higher risk for PID and TFI in chlamydia-positive women, but the incidence for ectopic pregnancy was comparable between chlamydia-positive and chlamydia-negative women. Overall, the incidence rates of sequelae remained low. NTR-5597.

Identifiants

pubmed: 30606817
pii: sextrans-2018-053778
doi: 10.1136/sextrans-2018-053778
pmc: PMC6585279
doi:

Banques de données

NTR
['NTR-5597']

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

300-306

Informations de copyright

© Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

Lancet Infect Dis. 2017 Aug;17(8):e235-e279
pubmed: 28701272
Clin Microbiol Rev. 2015 Oct;28(4):969-85
pubmed: 26310245
Hum Reprod. 2006 Jun;21(6):1533-8
pubmed: 16478761
J Infect Dis. 2010 Jun 15;201 Suppl 2:S134-55
pubmed: 20470050
Sex Transm Infect. 2018 Mar;94(2):100-104
pubmed: 28724744
Lancet Infect Dis. 2016 Sep;16(9):1057-1064
pubmed: 27289389
Sex Transm Infect. 2003 Dec;79(6):491-4
pubmed: 14663128
Health Technol Assess. 2007 Mar;11(8):iii-iv, ix-xii, 1-165
pubmed: 17311735
PLoS One. 2015 Dec 08;10(12):e0143304
pubmed: 26646541
BMC Infect Dis. 2017 Apr 11;17(1):264
pubmed: 28399813
J Clin Microbiol. 2002 Feb;40(2):584-7
pubmed: 11825974
PLoS One. 2017 Jan 27;12(1):e0152810
pubmed: 28129328
Cochrane Database Syst Rev. 2016 Sep 13;9:CD010866
pubmed: 27623210
BMJ. 2010 Apr 08;340:c1642
pubmed: 20378636
Am J Epidemiol. 2005 May 15;161(10):978-86
pubmed: 15870163
Sex Transm Dis. 2007 Oct;34(10):739-43
pubmed: 17479068
Clin Infect Dis. 2018 Jan 18;66(3):437-443
pubmed: 29136127
Sex Transm Infect. 2006 Jun;82(3):212-8
pubmed: 16731670
Int J Epidemiol. 2013 Apr;42(2):493-503
pubmed: 23505256
Int J Epidemiol. 2004 Apr;33(2):416-25
pubmed: 15082651
Obstet Gynecol. 2013 May;121(5):1091-8
pubmed: 23635748
FEMS Immunol Med Microbiol. 2009 Mar;55(2):140-53
pubmed: 19170753
J Microbiol Methods. 2018 Jan;144:164-167
pubmed: 29196272
Sex Transm Dis. 2005 Jun;32(6):377-81
pubmed: 15912085
Sex Transm Infect. 2016 Feb;92(1):63-6
pubmed: 26082320
Hum Reprod Update. 2010 Mar-Apr;16(2):189-204
pubmed: 19828674
BMJ. 2012 Jul 05;345:e4316
pubmed: 22767614
Health Technol Assess. 2016 Mar;20(22):1-250
pubmed: 27007215
Sex Transm Infect. 2014 Aug;90(5):434-40
pubmed: 24583966

Auteurs

Bernice M Hoenderboom (BM)

Epidemiology and Surveillance Unit, Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, The Netherlands bernice.hoenderboom@rivm.nl.
Laboratory of Immunogenetics, Department of Medical Microbiology and Infection Control, VU University Medical Center, Amsterdam, The Netherlands.

Birgit H B van Benthem (BHB)

Epidemiology and Surveillance Unit, Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, The Netherlands.

Jan E A M van Bergen (JEAM)

Epidemiology and Surveillance Unit, Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, The Netherlands.
Department of General Practice, Division Clinical Methods and Public Health, Academic Medical Center, Amsterdam, The Netherlands.
STI AIDS Netherlands (SOA AIDS Nederland), Amsterdam, The Netherlands.

Nicole H T M Dukers-Muijrers (NHTM)

Department of Sexual Health, Infectious Diseases and Environmental Health, South Limburg Public Health Service (GGD South Limburg), Geleen, The Netherlands.
Department of Medical Microbiology, Care and Public Health Research Institute (CAPHRI), Maastricht University Medical Centre (MUMC+), Maastricht, The Netherlands.

Hannelore M Götz (HM)

Epidemiology and Surveillance Unit, Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, The Netherlands.
Department Infectious Disease Control, Municipal Public Health Service Rotterdam-Rijnmond (GGD Rotterdam), Rotterdam, The Netherlands.
Department of Public Health, Erasmus MC-University Medical Center Rotterdam, Rotterdam, The Netherlands.

Christian J P A Hoebe (CJPA)

Department of Sexual Health, Infectious Diseases and Environmental Health, South Limburg Public Health Service (GGD South Limburg), Geleen, The Netherlands.
Department of Medical Microbiology, Care and Public Health Research Institute (CAPHRI), Maastricht University Medical Centre (MUMC+), Maastricht, The Netherlands.

Arjan A Hogewoning (AA)

STI Outpatient Clinic, Public Health Service of Amsterdam (GGD Amsterdam), Amsterdam, The Netherlands.

Jolande A Land (JA)

Department of Genetics and Cell Biology, Research School GROW (School for Oncology and Developmental Biology), Faculty of Health, Medicine and Life Sciences, Institute for Public Health Genomics (IPHG), University of Maastricht, Maastricht, The Netherlands.

Marianne A B van der Sande (MAB)

Epidemiology and Surveillance Unit, Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, The Netherlands.
Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands.
Department of Public Health, Institute of Tropical Medicine, Antwerp, Belgium.

Servaas A Morré (SA)

Laboratory of Immunogenetics, Department of Medical Microbiology and Infection Control, VU University Medical Center, Amsterdam, The Netherlands.
Department of Genetics and Cell Biology, Research School GROW (School for Oncology and Developmental Biology), Faculty of Health, Medicine and Life Sciences, Institute for Public Health Genomics (IPHG), University of Maastricht, Maastricht, The Netherlands.

Ingrid V F van den Broek (IVF)

Epidemiology and Surveillance Unit, Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, The Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH